NanoViricides
NNVC
29 hedge funds and large institutions have $1.86M invested in NanoViricides in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 13 closing their positions.
1,525% more call options, than puts
Call options by funds: $65K | Put options by funds: $4K
1.26% less ownership
Funds ownership: 7.35% → 6.09% (-1.3%)
19% less funds holding
Funds holding: 36 → 29 (-7)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
38% less capital invested
Capital invested by funds: $3.01M → $1.86M (-$1.14M)
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$275K |
| 2 |
Millennium Management
New York
|
+$79K |
| 3 |
OPS
Orion Portfolio Solutions
Omaha,
Nebraska
|
+$42.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$14.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$282K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$182K |
| 3 |
BlackRock
New York
|
-$107K |
| 4 |
Morgan Stanley
New York
|
-$77.5K |
| 5 |
Jane Street
New York
|
-$58K |
NNVC Hedge Fund Activity: Q4 2020 in Review
29 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q4 2020, worth a combined $1.86M — down 38% from $3.01M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of NNVC and 6 opened new positions — a net loss of 7 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $275K. The largest seller was Goldman Sachs, exiting entirely with an estimated $282K sold.
- 29 institutional investors held NanoViricides (NNVC) as of Q4 2020, down from 36 in Q3 2020.
- Funds reported $1.86M of NanoViricides stock for Q4 2020, down 38% quarter-over-quarter.
- 6 funds opened new NanoViricides positions in Q4 2020 and 13 closed out, a net change of -7 holders.
- The largest NanoViricides buyer in Q4 2020 was Renaissance Technologies, an estimated $275K added.
- The largest NanoViricides seller in Q4 2020 was Goldman Sachs, an estimated $282K sold.
Based on aggregated 13F filings for Q4 2020.